What other criteria are there to rank funding mechanisms upon, apart from access and innovation?

We propose to use the criteria of access and innovation to evaluate possible funding mechanisms. Several other factors for assessing funding mechanisms have been proposed, many of which fall within the remit of either access or innovation such as health impact/public health impact, delinking, dissemination and innovation incentive.

See also the funding mechanisms document in answer to this question.

We propose to use the criteria of access and innovation to evaluate possible funding mechanisms:


Several other factors for assessing funding mechanisms have been proposed.

Some of these criteria fall within the remit of either access of innovation:


Other criteria do not fall within this remit, but are being treated in this project as part of a separate workstream:


Further proposed criteria are not covered by access or innovation, but seem peripheral:


There are also other proposed criteria which merit further investigation, as they are neither encompassed by access or innovation, nor peripheral to our project:


Renwick, Brogan and Mossialos also present criteria for ranking funding mechanisms, but the criteria are specific to the antibiotic context.18

Bibliography

Hecht, Robert, Paul Wilson, and Amrita Palriwala. “Improving Health R&d Financing for Developing Countries: A Menu of Innovative Policy Options.” Health Affairs (Project Hope) 28, no. 4 (2009): 974–85. doi:10.1377/hlthaff.28.4.974.

Hoffman, Steven J., and Karen So. “Assessing 15 Proposals for Promoting Innovation and Access to Medicines Globally.” Annals of Global Health, Tropical Medicine in the Era of Global Connectivity, 80, no. 6 (2014): 432–43. doi:10.1016/j.aogh.2015.02.004.

Stiglitz, Joseph E. “Economic Foundations of Intellectual Property Rights.” Duke Law Journal 57, no. 6 (2008): 1693–1724. doi:10.230740040630.

“Research and Development to Meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination.” Report of the Consultative Expert Working Group on Research and Development: Financing and Coordination. World Health Organisation, 2012. http://apps.who.int/iris/bitstream/10665/254706/1/9789241503457-eng.pdf?ua=1.

Renwick, Matthew, David M. Brogan, and Elias Mossialos. “A Systematic Review and Critical Assessment of Incentive Strategies for Discovery and Development of Novel Antibiotics,” 2015. http://eprints.lse.ac.uk/64852/1/Mossialos_systematic_review_and_critical_assessment1.pdf.


  1. Hoffman and So, “Assessing 15 Proposals for Promoting Innovation and Access to Medicines Globally”, p. 433; “Research and Development to Meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination”, pp. 48-49. [return]
  2. “Research and Development to Meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination”, pp. 48-49. [return]
  3. “Research and Development to Meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination”, pp. 48-49. [return]
  4. Stiglitz, “Economic Foundations of Intellectual Property Rights”, p. 1722. [return]
  5. Stiglitz, “Economic Foundations of Intellectual Property Rights”, p. 1722. [return]
  6. Hecht, Wilson, and Palriwala, “Improving Health R&d Financing for Developing Countries”, p. 981. [return]
  7. Hecht, Wilson, and Palriwala, “Improving Health R&d Financing for Developing Countries”, p. 981. [return]
  8. Hoffman and So, “Assessing 15 Proposals for Promoting Innovation and Access to Medicines Globally”, p. 433. [return]
  9. “Research and Development to Meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination”, pp. 48-49. [return]
  10. Hecht, Wilson, and Palriwala, “Improving Health R&d Financing for Developing Countries”, p. 981. [return]
  11. Hoffman and So, “Assessing 15 Proposals for Promoting Innovation and Access to Medicines Globally”, p. 433. [return]
  12. Hecht, Wilson, and Palriwala, “Improving Health R&d Financing for Developing Countries”, p. 981. [return]
  13. “Research and Development to Meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination”, pp. 48-49. [return]
  14. Stiglitz, “Economic Foundations of Intellectual Property Rights”, p. 1722. [return]
  15. “Research and Development to Meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination”, pp. 48-49. [return]
  16. “Research and Development to Meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination”, pp. 48-49. [return]
  17. Hecht, Wilson, and Palriwala, “Improving Health R&d Financing for Developing Countries”, p. 981. [return]
  18. Renwick, Brogan, and Mossialos, “A Systematic Review and Critical Assessment of Incentive Strategies for Discovery and Development of Novel Antibiotics”, pp. 8-11. [return]